TR201006802A1 - Prasugrelin oral yolla dağılan formülasyonları. - Google Patents

Prasugrelin oral yolla dağılan formülasyonları.

Info

Publication number
TR201006802A1
TR201006802A1 TR2010/06802A TR201006802A TR201006802A1 TR 201006802 A1 TR201006802 A1 TR 201006802A1 TR 2010/06802 A TR2010/06802 A TR 2010/06802A TR 201006802 A TR201006802 A TR 201006802A TR 201006802 A1 TR201006802 A1 TR 201006802A1
Authority
TR
Turkey
Prior art keywords
prasugrelin
oral dispersible
dispersible formulations
pharmaceutically acceptable
formulations
Prior art date
Application number
TR2010/06802A
Other languages
English (en)
Inventor
Ümi̇t Çi̇fter Musa
Öner Levent
Türkyilmaz Ali̇
Original Assignee
Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel İlaç San. Ve Ti̇c. A.Ş. filed Critical Sanovel İlaç San. Ve Ti̇c. A.Ş.
Priority to TR2010/06802A priority Critical patent/TR201006802A1/tr
Priority to TR2010/07926A priority patent/TR201007926A1/tr
Priority to EP11174408.2A priority patent/EP2409689B1/en
Priority to EP11174395A priority patent/EP2409685A3/en
Priority to ES11174408.2T priority patent/ES2465998T3/es
Publication of TR201006802A1 publication Critical patent/TR201006802A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş oral yolla dağılan farmasötik bır formülasyon olup, prasugrel ya da bunun farmasötik olarak kabul edilebilir bır tuzu ıle bır ya da daha fazla farmasötik olarak kabul edilebilir eksipiyan içermektedir.
TR2010/06802A 2010-07-19 2010-08-17 Prasugrelin oral yolla dağılan formülasyonları. TR201006802A1 (tr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
TR2010/06802A TR201006802A1 (tr) 2010-08-17 2010-08-17 Prasugrelin oral yolla dağılan formülasyonları.
TR2010/07926A TR201007926A1 (tr) 2010-07-19 2010-09-29 Prasugrel tablet formülasyonları.
EP11174408.2A EP2409689B1 (en) 2010-07-19 2011-07-18 Prasugrel tablet formulations
EP11174395A EP2409685A3 (en) 2010-07-19 2011-07-18 Orally-disintegrating formulations of prasugrel
ES11174408.2T ES2465998T3 (es) 2010-07-19 2011-07-18 Formulaciones de comprimidos de prasugrel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2010/06802A TR201006802A1 (tr) 2010-08-17 2010-08-17 Prasugrelin oral yolla dağılan formülasyonları.

Publications (1)

Publication Number Publication Date
TR201006802A1 true TR201006802A1 (tr) 2012-03-21

Family

ID=43606402

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2010/06802A TR201006802A1 (tr) 2010-07-19 2010-08-17 Prasugrelin oral yolla dağılan formülasyonları.

Country Status (1)

Country Link
TR (1) TR201006802A1 (tr)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1298132A1 (en) * 2000-07-06 2003-04-02 Sankyo Company, Limited Hydropyridine derivative acid addition salts
JP2003246735A (ja) * 2001-12-21 2003-09-02 Sankyo Co Ltd ヒドロピリジン誘導体酸付加塩を含有する医薬
WO2004098713A2 (en) * 2003-05-05 2004-11-18 Eli Lilly And Company Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
WO2006135605A2 (en) * 2005-06-10 2006-12-21 Eli Lilly And Company Formulation of a thienopyridine platelet aggregation inhibitor
WO2006138317A2 (en) * 2005-06-17 2006-12-28 Eli Lilly And Company Dosage regimen for prasugrel
WO2008073759A2 (en) * 2006-12-07 2008-06-19 Eli Lilly And Company An article comprising prasugrel
EP2100607A1 (en) * 2006-12-07 2009-09-16 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved storage stability
US20090281136A1 (en) * 2008-05-08 2009-11-12 Sandeep Mhetre Prasugrel pharmaceutical formulations
US20090291138A1 (en) * 2006-12-07 2009-11-26 Daiichi Sankyo Company, Limited Film-coated preparation having improved stability

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1298132A1 (en) * 2000-07-06 2003-04-02 Sankyo Company, Limited Hydropyridine derivative acid addition salts
JP2003246735A (ja) * 2001-12-21 2003-09-02 Sankyo Co Ltd ヒドロピリジン誘導体酸付加塩を含有する医薬
WO2004098713A2 (en) * 2003-05-05 2004-11-18 Eli Lilly And Company Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
WO2006135605A2 (en) * 2005-06-10 2006-12-21 Eli Lilly And Company Formulation of a thienopyridine platelet aggregation inhibitor
WO2006138317A2 (en) * 2005-06-17 2006-12-28 Eli Lilly And Company Dosage regimen for prasugrel
WO2008073759A2 (en) * 2006-12-07 2008-06-19 Eli Lilly And Company An article comprising prasugrel
EP2100607A1 (en) * 2006-12-07 2009-09-16 Daiichi Sankyo Company, Limited Pharmaceutical composition having improved storage stability
US20090291138A1 (en) * 2006-12-07 2009-11-26 Daiichi Sankyo Company, Limited Film-coated preparation having improved stability
US20090281136A1 (en) * 2008-05-08 2009-11-12 Sandeep Mhetre Prasugrel pharmaceutical formulations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 200379, Derwent World Patents Index; AN 2003-847929, XP002619601 *

Similar Documents

Publication Publication Date Title
CY1124007T1 (el) Στοματικες δοσολογικες μορφες παρατεταμενης απελευθερωσης τοφασιτινιμπης
CY1125100T1 (el) Υδατικο φαρμακευτικο σκευασμα ταπενταδολης για απο του στοματος χορηγηση
CY1119007T1 (el) Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης
EP3256149A4 (en) FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS
CY1121999T1 (el) Φαρμακοτεχνικες μορφες συνδυασμου δαρουναβιρης
AU2018231044A8 (en) Pharmaceutical formulations of phloroglucinol and trimethylphloroglucinol
MX2013001985A (es) Formulaciones a base de nalbufina y sus usos
WO2011101863A3 (en) Extended release pharmaceutical compositions of lacosamide
CY1124041T1 (el) Συνθεσεις που περιλαμβανουν κυκλοσπορινη
MX341976B (es) Formulaciones de darunavir.
EP3500291A4 (en) FORMULATIONS FOR THE ORAL ADMINISTRATION OF ACTIVE AGENTS
TN2011000651A1 (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine their preparation and their therapeutic application
EA201291104A1 (ru) Пероральные лекарственные формы бендамустина
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
TR201009394A2 (tr) Geliştirilmiş montelukast formülasyonları.
MX364946B (es) Sistema adyuvante mejorado para la administración de vacunas orales.
WO2019151964A3 (en) Orally disintegrating formulations of saxagliptin
EP2409685A3 (en) Orally-disintegrating formulations of prasugrel
TR201007926A1 (tr) Prasugrel tablet formülasyonları.
TR201006802A1 (tr) Prasugrelin oral yolla dağılan formülasyonları.
TR200903548A1 (tr) Oral yolla dağılan emoksipin bileşimleri
IN2013MU03309A (tr)
TR201002084A1 (tr) Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi
TR201720510A2 (tr) Orally disintegrating tablet formulations of ivabradine
EP4081218A4 (en) ORODISPERSIBLE FORMULATIONS OF PRUCALOPRIDE